Aulisa Medical USA, Inc.
- Industry
- Medical Device Manufacturing
- Founded Year
- 2012
- Headquarters
- 999 Commercial St, Palo Alto, California, 94303, United States
- Employee Count
- 0
Key People
- Augie Lien - Founder, Chairman & CEO
- Kenneth Abriola - Vice President of Sales and Marketing
- Preston Wilson - Director - Sales and Marketing
- Soraya Kaliel - Territory Sales Manager
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: Led by Augie Lien, a serial entrepreneur with multiple successful MedTech ventures.
Augie Lien has founded several successful MedTech companies, including Nellcor and Cardiva Medical, indicating robust leadership and industry experience.
- Clinical Need
-
Aspect: Very Strong
Summary: Addresses critical need for continuous, remote vital signs monitoring.
The increasing prevalence of chronic diseases and the shift towards home healthcare create a strong demand for continuous, remote monitoring solutions like those offered by Aulisa.
- Competition
-
Aspect: Somewhat crowded
Summary: Competes in a market with several established players.
The patient monitoring market includes several established companies, making it somewhat crowded and challenging for new entrants to gain significant market share.
- Technical Challenge
-
Aspect: Predictable
Summary: Technology is well-understood with manageable development risks.
The development of wireless, wearable monitoring devices involves known technologies, reducing the risk of unforeseen technical challenges.
- Patent
-
Aspect: Strong
Summary: Possesses strong intellectual property protection.
Aulisa's proprietary innovations in wireless, wearable monitoring systems are protected by strong patents, providing a competitive advantage.
- Financing
-
Aspect: Well-funded
Summary: Secured significant funding to support growth.
The $13 million Series A funding provides the necessary capital for product development and market expansion.
- Regulatory
-
Aspect: 510k/PMA
Summary: Products are FDA-cleared, facilitating market entry.
Aulisa's products have received FDA clearance, streamlining the process for market introduction and adoption.
Opportunity Rollup
- Odds of Success
- 3.7
- Peak Market Share
- 4.7
- Segment CAGR
- 3.6%
- Market Segment
- Patient Monitoring
- Market Sub Segment
- Wireless Wearable Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.24 |
| 2 | 0.70 |
| 3 | 1.64 |
| 4 | 3.29 |
| 5 | 4.70 |
Key Takeaway
Aulisa Medical USA, Inc. is well-positioned in the growing patient monitoring market, leveraging strong leadership and innovative technology to meet increasing demand for remote healthcare solutions.